Ownership & Insider Lab

Look up a company to review current SEC-traceable insider positions, exact reporting-owner relationships across other published companies, a dated chronology of the published ownership evidence, and recent supported insider transactions where transaction history is separately available.
Coverage follows the existing reviewed company dataset and fails closed when a ticker is not currently supported.

Roivant Sciences Ltd. (ROIV)

Nasdaq · SEC CIK 0001635088

$730.02MCovered current disclosed holdings
4Covered reporting owners
4Covered direct positions
4Source ownership filings

This is the supported SEC-traceable subset, not total insider ownership or personal wealth. Values reflect the current disclosed positions Grizzly Bulls can resolve and value. Latest source filing: Sep 18, 2026 · values through Sep 25, 2026.

Covered reporting owners

Filter the reporting-owner snapshot by holder, role, or security. Position values are shown only where the current reviewed data supports them.

4 shown
HolderRolePositionCurrent valueLatest filing
Mayukh SukhatmeResearch disclosed relationshipsPresident & CIO · Director18,630,739 sharesCommon Shares, $0.0000000341740141 per share$667.26MAug 21, 2026
Eric VenkerResearch disclosed relationshipsPresident & Immunovant CEO1,599,154 sharesCommon Shares, $0.0000000341740141 per share$57.27MSep 1, 2026
James C. MomtazeeResearch disclosed relationshipsDirector111,959 sharesCommon Shares, $0.0000000341740141 per share$4.01MSep 18, 2026
Meghan FitzgeraldResearch disclosed relationshipsDirector41,162 sharesCommon Shares, $0.0000000341740141 per share$1.47MSep 18, 2026

Reporting-owner research graph

These relationships are joined only when the same single SEC reporting-owner CIK appears unambiguously across the publication-authorized company ownership universe. Name similarity is never used to create a relationship.

This graph is bounded to the company ownership relationships currently published by Grizzly Bulls. It is not a complete employment, board, ownership, portfolio, or wealth history, and a missing relationship does not establish that none exists.

SEC transaction evidence ledger

Each row preserves the reviewed SEC transaction evidence, including the effective-date basis, amendment state, reported post-transaction position when present, and a separately published current covered owner/security position when one can be matched uniquely. Reported price is shown when present. The lab does not calculate gross proceeds, reconstruct balances between filings, or treat historical transactions as current wealth.

24 shown
Effective dateHolderActionSecurityUnitsReported priceReported position after transactionCurrent covered positionFiling
Oct 16, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsDispositionSEC code FCommon Shares, $0.0000000341740141 per share19,976 shares$33.5318,563,884 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Oct 20, 2026
Sep 30, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsDispositionSEC code FCommon Shares, $0.0000000341740141 per share46,879 shares$36.5718,583,860 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Oct 2, 2026
Sep 30, 2026Transaction dateEric VenkerResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share200,000 shares$36.621,599,154 shares1,599,154 sharesOwner coverage latest filing Sep 1, 20264Filed Oct 2, 2026
Sep 30, 2026Transaction dateEric VenkerResearch disclosed relationshipsAcquisitionSEC code MCommon Shares, $0.0000000341740141 per share200,000 shares$3.851,799,154 shares1,599,154 sharesOwner coverage latest filing Sep 1, 20264Filed Oct 2, 2026
Sep 16, 2026Transaction dateMeghan FitzgeraldResearch disclosed relationshipsAcquisitionSEC code ACommon Shares, $0.0000000341740141 per share5,054 shares$041,162 shares41,162 sharesOwner coverage latest filing Sep 18, 20264Filed Sep 18, 2026
Sep 16, 2026Transaction dateJames C. MomtazeeResearch disclosed relationshipsAcquisitionSEC code ACommon Shares, $0.0000000341740141 per share5,054 shares$0111,959 shares111,959 sharesOwner coverage latest filing Sep 18, 20264Filed Sep 18, 2026
Sep 15, 2026Transaction dateMeghan FitzgeraldResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share400 shares$40.4536,108 shares41,162 sharesOwner coverage latest filing Sep 18, 20264Filed Sep 17, 2026
Sep 15, 2026Transaction dateMeghan FitzgeraldResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share4,712 shares$39.6836,508 shares41,162 sharesOwner coverage latest filing Sep 18, 20264Filed Sep 17, 2026
Sep 10, 2026Transaction dateMeghan FitzgeraldResearch disclosed relationshipsDispositionSEC code FCommon Shares, $0.0000000341740141 per share1,743 shares$40.9441,220 shares41,162 sharesOwner coverage latest filing Sep 18, 20264Filed Sep 14, 2026
Sep 10, 2026Transaction dateJames C. MomtazeeResearch disclosed relationshipsDispositionSEC code FCommon Shares, $0.0000000341740141 per share2,905 shares$40.94106,905 shares111,959 sharesOwner coverage latest filing Sep 18, 20264Filed Sep 14, 2026
Sep 8, 2026Transaction dateMeghan FitzgeraldResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share20,000 shares$39.942,963 shares41,162 sharesOwner coverage latest filing Sep 18, 20264Filed Sep 10, 2026
Sep 8, 2026Transaction dateMeghan FitzgeraldResearch disclosed relationshipsAcquisitionSEC code MCommon Shares, $0.0000000341740141 per share20,000 shares$8.862,963 shares41,162 sharesOwner coverage latest filing Sep 18, 20264Filed Sep 10, 2026
Aug 28, 2026Transaction dateEric VenkerResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share33,818 shares$36.441,599,154 shares1,599,154 sharesOwner coverage latest filing Sep 1, 20264Filed Sep 1, 2026
Aug 28, 2026Transaction dateEric VenkerResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share166,182 shares$35.631,632,972 shares1,599,154 sharesOwner coverage latest filing Sep 1, 20264Filed Sep 1, 2026
Aug 28, 2026Transaction dateEric VenkerResearch disclosed relationshipsAcquisitionSEC code MCommon Shares, $0.0000000341740141 per share200,000 shares$3.851,799,154 shares1,599,154 sharesOwner coverage latest filing Sep 1, 20264Filed Sep 1, 2026
Aug 21, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share144,756 shares$36.4818,630,739 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Aug 21, 2026
Aug 21, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsAcquisitionSEC code MCommon Shares, $0.0000000341740141 per share144,756 shares$3.8518,775,495 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Aug 21, 2026
Aug 20, 2026Transaction dateEric VenkerResearch disclosed relationshipsDispositionSEC code FCommon Shares, $0.0000000341740141 per share13,909 shares$36.841,599,154 shares1,599,154 sharesOwner coverage latest filing Sep 1, 20264Filed Aug 24, 2026
Aug 20, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share17,519 shares$37.318,630,739 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Aug 21, 2026
Aug 20, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsAcquisitionSEC code MCommon Shares, $0.0000000341740141 per share17,519 shares$3.8518,648,258 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Aug 21, 2026
Aug 19, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share172,899 shares$37.1718,630,739 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Aug 21, 2026
Aug 19, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsAcquisitionSEC code MCommon Shares, $0.0000000341740141 per share172,899 shares$3.8518,803,638 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Aug 21, 2026
Aug 18, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsSaleSEC code SCommon Shares, $0.0000000341740141 per share31,801 shares$37.1818,630,739 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Aug 18, 2026
Aug 18, 2026Transaction dateMayukh SukhatmeResearch disclosed relationshipsAcquisitionSEC code MCommon Shares, $0.0000000341740141 per share31,801 shares$3.8518,662,540 shares18,630,739 sharesOwner coverage latest filing Aug 21, 20264Filed Aug 18, 2026

A reported post-transaction position is the balance stated in that historical transaction filing. A current covered position is a separate latest owner/security observation and may reflect later filings or activity. They are shown side by side as evidence points, not as a reconstructed continuous ledger.

Published 24 of 36 source candidates under the current reviewed security-resolution rules.

Covered securities

SecurityInstrument familyCovered positionsCovered value
Common Shares, $0.0000000341740141 per shareordinary-share4$730.02M

Coverage and interpretation

Current holdings: direct positions that the reviewed ownership data can trace to an exact reporting owner, legal security, and current-basis quantity.

Current value: the existing published company-position valuation. This lab does not recalculate security values or infer missing positions.

Transaction evidence: historical flow observations with filing provenance. Reported post-transaction balances and current covered positions are separate evidence points; the lab does not interpolate ownership between them.

Reporting-owner graph: exact reporting-owner CIK relationships across the published company universe. It does not merge people by name or create a complete personal history.

Not included here: a claim of total insider ownership, total personal wealth, institutional 13F ownership, a transaction-value estimate, an insider sentiment score, or an investment recommendation.

Published ownership evidence chronology

This sequence orders only the ownership evidence already published by Grizzly Bulls for the exact reporting-owner relationships above. Transaction rows are ordered by filing date while preserving the separate economic effective date and its basis. Current covered snapshots remain separate latest observations.

The chronology does not interpolate ownership between entries, infer missing activity, pair an amended filing with an assumed parent, infer amendment supersession, or treat a current covered snapshot as proof of continuous ownership.

Eric Venker

SEC reporting-owner CIK 0001801917 · 1 published relationship company

SEC owner filings
Evidence dateCompanyObservationSecurity / positionSource
Oct 2, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code MEffective Sep 30, 2026 · transaction dateReported units 200,000 shares · reported price 3.85Common Shares, $0.0000000341740141 per shareReported position after transaction: 1,799,154 shares4 filing0001635088-26-000108
Oct 2, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Sep 30, 2026 · transaction dateReported units 200,000 shares · reported price 36.62Common Shares, $0.0000000341740141 per shareReported position after transaction: 1,599,154 shares4 filing0001635088-26-000108
Sep 1, 2026Latest represented filing dateRoivant Sciences Ltd. (ROIV)NasdaqCurrent covered snapshotPresident & Immunovant CEOValuation observation Sep 25, 2026Common Shares, $0.0000000341740141 per share: 1,599,154 sharesCurrent covered company value: $57.27MPublished current ownership snapshotForms represented: 4Owner filingsIssuer filings
Sep 1, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code MEffective Aug 28, 2026 · transaction dateReported units 200,000 shares · reported price 3.85Common Shares, $0.0000000341740141 per shareReported position after transaction: 1,799,154 shares4 filing0001140361-26-035375
Sep 1, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Aug 28, 2026 · transaction dateReported units 166,182 shares · reported price 35.63Common Shares, $0.0000000341740141 per shareReported position after transaction: 1,632,972 shares4 filing0001140361-26-035375
Sep 1, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Aug 28, 2026 · transaction dateReported units 33,818 shares · reported price 36.44Common Shares, $0.0000000341740141 per shareReported position after transaction: 1,599,154 shares4 filing0001140361-26-035375
Aug 24, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqDispositionSEC code FEffective Aug 20, 2026 · transaction dateReported units 13,909 shares · reported price 36.84Common Shares, $0.0000000341740141 per shareReported position after transaction: 1,599,154 shares4 filing0001140361-26-034238

Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 6 published transaction rows for this exact reporting-owner CIK appear in the chronology. 1 relationship company is at the current public transaction-row limit; that does not prove additional rows exist.

James C. Momtazee

SEC reporting-owner CIK 0001209181 · 1 published relationship company

SEC owner filings
Evidence dateCompanyObservationSecurity / positionSource
Sep 18, 2026Latest represented filing dateRoivant Sciences Ltd. (ROIV)NasdaqCurrent covered snapshotDirectorValuation observation Sep 25, 2026Common Shares, $0.0000000341740141 per share: 111,959 sharesCurrent covered company value: $4.01MPublished current ownership snapshotForms represented: 4Owner filingsIssuer filings
Sep 18, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code AEffective Sep 16, 2026 · transaction dateReported units 5,054 shares · reported price 0Common Shares, $0.0000000341740141 per shareReported position after transaction: 111,959 shares4 filing0001209181-26-000007
Sep 14, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqDispositionSEC code FEffective Sep 10, 2026 · transaction dateReported units 2,905 shares · reported price 40.94Common Shares, $0.0000000341740141 per shareReported position after transaction: 106,905 shares4 filing0001209181-26-000005

Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 2 published transaction rows for this exact reporting-owner CIK appear in the chronology. 1 relationship company is at the current public transaction-row limit; that does not prove additional rows exist.

Mayukh Sukhatme

SEC reporting-owner CIK 0001750050 · 1 published relationship company

SEC owner filings
Evidence dateCompanyObservationSecurity / positionSource
Oct 20, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqDispositionSEC code FEffective Oct 16, 2026 · transaction dateReported units 19,976 shares · reported price 33.53Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,563,884 shares4 filing0001635088-26-000114
Oct 2, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqDispositionSEC code FEffective Sep 30, 2026 · transaction dateReported units 46,879 shares · reported price 36.57Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,583,860 shares4 filing0001635088-26-000109
Aug 21, 2026Latest represented filing dateRoivant Sciences Ltd. (ROIV)NasdaqCurrent covered snapshotPresident & CIO · DirectorValuation observation Sep 25, 2026Common Shares, $0.0000000341740141 per share: 18,630,739 sharesCurrent covered company value: $667.26MPublished current ownership snapshotForms represented: 4Owner filingsIssuer filings
Aug 21, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code MEffective Aug 19, 2026 · transaction dateReported units 172,899 shares · reported price 3.85Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,803,638 shares4 filing0001140361-26-034066
Aug 21, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Aug 19, 2026 · transaction dateReported units 172,899 shares · reported price 37.17Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,630,739 shares4 filing0001140361-26-034066
Aug 21, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code MEffective Aug 20, 2026 · transaction dateReported units 17,519 shares · reported price 3.85Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,648,258 shares4 filing0001140361-26-034066
Aug 21, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Aug 20, 2026 · transaction dateReported units 17,519 shares · reported price 37.3Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,630,739 shares4 filing0001140361-26-034066
Aug 21, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code MEffective Aug 21, 2026 · transaction dateReported units 144,756 shares · reported price 3.85Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,775,495 shares4 filing0001140361-26-034066
Aug 21, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Aug 21, 2026 · transaction dateReported units 144,756 shares · reported price 36.48Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,630,739 shares4 filing0001140361-26-034066
Aug 18, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code MEffective Aug 18, 2026 · transaction dateReported units 31,801 shares · reported price 3.85Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,662,540 shares4 filing0001140361-26-033637
Aug 18, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Aug 18, 2026 · transaction dateReported units 31,801 shares · reported price 37.18Common Shares, $0.0000000341740141 per shareReported position after transaction: 18,630,739 shares4 filing0001140361-26-033637

Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 10 published transaction rows for this exact reporting-owner CIK appear in the chronology. 1 relationship company is at the current public transaction-row limit; that does not prove additional rows exist.

Meghan Fitzgerald

SEC reporting-owner CIK 0001349297 · 1 published relationship company

SEC owner filings
Evidence dateCompanyObservationSecurity / positionSource
Sep 18, 2026Latest represented filing dateRoivant Sciences Ltd. (ROIV)NasdaqCurrent covered snapshotDirectorValuation observation Sep 25, 2026Common Shares, $0.0000000341740141 per share: 41,162 sharesCurrent covered company value: $1.47MPublished current ownership snapshotForms represented: 4Owner filingsIssuer filings
Sep 18, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code AEffective Sep 16, 2026 · transaction dateReported units 5,054 shares · reported price 0Common Shares, $0.0000000341740141 per shareReported position after transaction: 41,162 shares4 filing0001349297-26-000010
Sep 17, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Sep 15, 2026 · transaction dateReported units 4,712 shares · reported price 39.68Common Shares, $0.0000000341740141 per shareReported position after transaction: 36,508 shares4 filing0001349297-26-000008
Sep 17, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Sep 15, 2026 · transaction dateReported units 400 shares · reported price 40.45Common Shares, $0.0000000341740141 per shareReported position after transaction: 36,108 shares4 filing0001349297-26-000008
Sep 14, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqDispositionSEC code FEffective Sep 10, 2026 · transaction dateReported units 1,743 shares · reported price 40.94Common Shares, $0.0000000341740141 per shareReported position after transaction: 41,220 shares4 filing0001349297-26-000006
Sep 10, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqAcquisitionSEC code MEffective Sep 8, 2026 · transaction dateReported units 20,000 shares · reported price 8.8Common Shares, $0.0000000341740141 per shareReported position after transaction: 62,963 shares4 filing0001140361-26-036246
Sep 10, 2026Filed dateRoivant Sciences Ltd. (ROIV)NasdaqSaleSEC code SEffective Sep 8, 2026 · transaction dateReported units 20,000 shares · reported price 39.9Common Shares, $0.0000000341740141 per shareReported position after transaction: 42,963 shares4 filing0001140361-26-036246

Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 6 published transaction rows for this exact reporting-owner CIK appear in the chronology. 1 relationship company is at the current public transaction-row limit; that does not prove additional rows exist.

Continue this ownership research

These handoffs preserve the exact company identities already represented in the reporting-owner graph. My Stocks keeps a listed company in your existing research lists. Research Inbox is a separate company-change update workflow.

Saving a company to My Stocks never enables updates, and opening Research Inbox never subscribes you automatically. Each update remains an explicit company-level opt-in under the existing Research Inbox consent flow.

CompanyReporting-owner contextPublished evidenceContinue research
Roivant Sciences Ltd. (ROIV)Nasdaq · Current company28Published chronology observationsLatest represented evidence Oct 20, 2026

These are company-level continuation paths, not reporting-owner subscriptions. Saving or watching one company does not automatically save or watch the other companies connected to the same reporting owner, and it does not create an owner-level alert.